Company news

Heartseed, Inc. news in 2026

Heartseed, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Notice Regarding the First Patient Dosed in the Ischemic Heart Disease Cohort in the Phase I/II company-sponsored Clinical Trial of HS-005

October 27, 2026

Notice on Resignation of Independent Board Director

September 17, 2026

Non-consolidated Financial Results for the Six Months Ended June 30, 2026 (Under Japanese GAAP)

August 14, 2026

Notice Regarding the First Patient Dosed in the Phase I/II company-sponsored Clinical Trial of HS-005 (Catheter Administration) for Cardiac Remuscular

June 12, 2026

Decks in 2026